MDMA and heightened cortisol: a neurohormonal perspective on the pregnancy outcomes of mothers used 'Ecstasy' during pregnancy.
MDMA and heightened cortisol: a neurohormonal perspective on the pregnancy outcomes of mothers used 'Ecstasy' during pregnancy.
复制标题
MDMA 和皮质醇升高:从神经激素角度看待怀孕期间使用“摇头丸”的母亲的妊娠结局。
DOI:
10.1002/hup.2342
复制
发表时间:
2014
期刊:
影响因子:
--
通讯作者:
Singer,LynnT
中科院分区:
文献类型:
--
作者:
Parrott,AndrewC;Moore,DerekG;Turner,JohnJD;Goodwin,Julia;Min,MeeyoungO;Singer,LynnT
ObjectiveThe illicit recreational drug 3,4‐methylenedioxymethamphetamine (MDMA) or Ecstasy has strong neurohormonal effects. When taken by recreational users at dance clubs and raves, it can generate an 800% increase in the stress hormone cortisol, whereas drug‐free users show chronically raised levels of cortisol. The aim here is to critically debate this neurohormonal influence for the children of pregnant MDMA‐using mothers.MethodsHigh levels of cortisol are known to be damaging for neuropsychobiological well‐being in adult humans. MDMA can damage foetal development in laboratory animals, and the prospective Drugs and Infancy Study was established to monitor the effects of MDMA taken recreationally by pregnant women.ResultsThe Drugs and Infancy Study revealed that young mothers, who took MDMA during the first trimester of pregnancy, gave birth to babies with significant gross psychomotor retardation. These mothers would have experienced high levels of cortisol due to Ecstasy/MDMA use, and since cortisol can cross the placenta, this is likely to have also occurred in the foetus.ConclusionsIn terms of causation, the developmental problems may reflect a combination of neurotransmitter and neurohormonal effects on the hypothalamic–pituitary–adrenal axis, with serotonergic activity being influenced by the high levels of cortisol. Copyright © 2014 John Wiley & Sons, Ltd.